✓ Last verified: February 3, 2026 — Edited & verified by Angelica Bottaro for HealingMaps Editorial Staff

Known For: Greenbrook TMS Claremont serves the Inland Empire’s western corridor from its Upland location on North Mountain Avenue. As part of the national Greenbrook network, this center offers insurance-covered Spravato (esketamine nasal spray) and NeuroStar TMS therapy for treatment-resistant depression and MDD with suicidal ideation. The location is convenient for patients in Upland, Claremont, Rancho Cucamonga, Pomona, and surrounding San Bernardino County communities seeking FDA-approved, insurance-covered depression treatments.
| Google Reviews | ⭐ 4.5 (National Network) |
| Location | Upland, California |
| Address | 820 North Mountain Avenue, Suite 215, Upland, CA 91786 |
| Phone | (855) 940-4867 |
| Website | greenbrooktms.com |
| Treatments | Spravato (Esketamine Nasal Spray), NeuroStar TMS Therapy |
| Conditions Treated | Treatment-Resistant Depression, MDD with Suicidal Ideation |
| Cost | Covered by most major insurance plans |
| Insurance | Most major insurance accepted for both Spravato and TMS |
| KAP Available | No — Spravato administered under medical supervision (not KAP) |
| Clinical Lead | Greenbrook TMS Clinical Team |
HealingMaps Take: The western Inland Empire has limited advanced depression treatment options, making this Greenbrook location a valuable resource for Upland, Claremont, and Rancho Cucamonga residents. Insurance coverage for both Spravato and TMS means patients can access ketamine-derived treatment without the $400–$800 per session cost typical of self-pay IV ketamine clinics. While Spravato is a different experience than IV ketamine infusions, it’s FDA-approved and backed by strong clinical evidence for treatment-resistant depression.
Market Position: Greenbrook TMS (Claremont) is a Spravato-certified clinic in the Upland metro. Spravato (esketamine) is the FDA-approved ketamine treatment that most commercial insurance plans cover after prior authorization — unlike cash-pay IV ketamine.
⚠ FDA-cleared indications for TMS therapy: treatment-resistant major depressive disorder (MDD), obsessive-compulsive disorder (OCD, Deep TMS only), anxious depression, short-term smoking cessation, and adolescent MDD (ages 15–21). Use of TMS for other conditions including PTSD, bipolar depression, fibromyalgia, and other indications is off-label — not currently FDA-cleared for those specific indications. Discuss your condition with the clinic to understand insurance coverage and clinical evidence.
Industry pricing reference. Greenbrook TMS (Claremont)’s posted price: Covered by most major insurance plans. Contact the clinic for any package or sliding-scale options. The calculator above shows metro-level cost estimates across protocols.
| Protocol | Typical Industry Cost | Offered Here |
|---|---|---|
| IV Ketamine | $350–$650/session | — |
| Spravato (esketamine) | $0–$250 copay (insured) | ✓ Yes |
| IM Ketamine | $250–$400/injection | — |
| KAP (with therapist) | $400–$1,200/session | — |
| At-home troches | $150–$300/month | — |
This 2-question summary is matched to the protocols and conditions Greenbrook TMS (Claremont) treats. Editorial responses are HealingMaps-authored, grounded in our 2026 Ketamine Clinic Intelligence Report.
Yes — Greenbrook TMS (Claremont) offers Spravato, which means they’re FDA REMS-certified and maintain the required two-hour in-office monitoring window after each dose. Spravato is the primary insurance-covered ketamine option for treatment-resistant depression. Worth confirming the prior-authorization timeline before booking your first session.
Greenbrook TMS (Claremont) treats depression via Spravato (FDA-cleared for TRD). The Spravato pathway is the most likely to obtain commercial insurance coverage. TRD is typically defined as two or more prior antidepressant trials without sufficient response — patients meeting that bar are best candidates here.
TMS therapy is also available at this clinic, alongside ketamine and Spravato. Unlike cash-pay ketamine, TMS is covered by most major insurance plans for treatment-resistant depression. TMS is FDA-cleared for treatment-resistant depression (since 2008), OCD via Deep TMS, anxious depression, and adolescent MDD ages 15–21. This clinic uses BrainsWay Deep TMS, the only TMS device with standalone FDA clearance for OCD via the H7 coil. Read our complete guide to TMS therapy for FDA-cleared conditions, device differences, insurance coverage by carrier, and what to expect at your first appointment. Browse verified TMS clinics in our directory.
View all REMS-certified Spravato clinics in California and across the United States.
Save 40%+ on Your Medical Supplies
GPO-level pricing negotiated through Pipeline Medical, exclusively for Healing Health Alliance members. Find out how much we can save your clinic — no obligation, no contracts.
Leave a Reply